Literature DB >> 88260

Surface antigens of human glioma cells shared with normal adult and fetal brain.

C J Wikstrand, D D Bigner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 88260

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  8 in total

1.  Binding specificity of two monoclonal antiglioma antibodies: immunocytochemical studies using a new tissue embedding technique.

Authors:  S Krajewski; G Schwendemann; M Weizsäcker; W Wechsler; N de Tribolet
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

Review 2.  The immunobiology of human gliomas.

Authors:  V Piguet; A C Diserens; S Carrel; J P Mach; N de Tribolet
Journal:  Springer Semin Immunopathol       Date:  1985

Review 3.  Immunobiologic aspects of the brain and human gliomas. A review.

Authors:  C J Wikstrand; D D Bigner
Journal:  Am J Pathol       Date:  1980-02       Impact factor: 4.307

Review 4.  Differential expression of glial- and neuronal-associated antigens in human tumors of the central and peripheral nervous system.

Authors:  G Reifenberger; J Szymas; W Wechsler
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

5.  Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system.

Authors:  J H Sampson; G E Archer; D M Ashley; H E Fuchs; L P Hale; G Dranoff; D D Bigner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

6.  Human antibody to OFA-I, a tumor antigen, produced in vitro by Epstein-Barr virus-transformed human B-lymphoid cell lines.

Authors:  R F Irie; L L Sze; R E Saxton
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

7.  Human glioma associated and related antigens, identified by monoclonal antibodies.

Authors:  J Yoshida; N Kageyama; R Ueda; T Takahashi
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

8.  A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas.

Authors:  D E Bullard; D G Thomas; J L Darling; C J Wikstrand; J V Diengdoh; R O Barnard; J G Bodmer; D D Bigner
Journal:  Br J Cancer       Date:  1985-02       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.